Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Search Results 1-10 of 11 for Cholecystokinin
Make sure you tell your doctor if you have any other medical problems, especially: Blockage of the intestines-The use of cholecystokinin may make this problem worse DRG-20062785 Drugs & Supplements Cholecystokinin (I...
DRG-20062785 Drugs & Supplements Cholecystokinin (Injection Route)
Cholecystokinin is used only under the supervision of a doctor.
Effect of Cholecystokinin (CCK) on Gastroduodenal Activity in Humans - Mayo Clinic Overview Tab Title Description Study type Interventional Study IDs Study type Interventional Describes the nature of a clinical study.
A Study of Function of Special Receptors Called Cholecystokinin (CCK) Receptors Located within the Gallbladder - Mayo Clinic Overview Tab Title Description Study type Observational Study IDs Study type Observational Describes the nat...
Miller's laboratory, which has portfolios of projects directed toward the class A cholecystokinin (CCK) receptor and the class B secretin receptor.
Miller Projects Class A G Protein-Coupled Receptor (GPCR) Projects Use of photoaffinity labeling and mutagenesis to explore the molecular basis of natural cholecystokinin (CCK) ligand binding to its receptor and refine our understand...
This has focused particularly on cholecystokinin (CCK)-gastrin and secretin-vasoactive intestinal polypeptide (VIP)-glucagon-like peptide families of peptides and receptors.
The injurious signaling shown is modeled by high-dose cholecystokinin (↑CKK), commonly used to cause mild, self-limited acute pancreatitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.